Altre lingue Roquefort Therapeutics plc

Azioni

ROQ

GB00BMDQ2T15

Mercato chiuso - London S.E. Altri mercati azionari 17:35:00 09/05/2024			Variaz. 5gg	Var. 1 gen.
4,55 ^GBX	0,00%		+3,41%	-37,24%

26/04	Roquefort Therapeutics plc riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
05/04	Roquefort annulla la raccolta di fondi dopo movimenti azionari "insoliti	AN

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany	26/04
Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Reports FY23 Loss GBX-1.35	26/04
Roquefort Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Roquefort cancels fundraise after "unusual" stock movements	05/04
Roquefort Therapeutics Shelves Potential Placing Following Unusual Price Movements	05/04
Roquefort celebrates "significant milestones" in cancer research	11/03
Roquefort Therapeutics plc Provides an Update on the Development of the Midkine Midkine mRNA and STAT-6 siRNA programs	11/03
Roquefort Therapeutics plc - Operations Update	07/02
Roquefort hails further MK studies, licence talks continue	06/02
Roquefort Therapeutics plc Provides an Update on Its Pre-Clinical Drug Development Programs	06/02
Roquefort Therapeutics Announces Significant Mesodermal Killer Cell Milestone	06/11
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO	27/09/23
Roquefort Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	27/09/23
Roquefort Therapeutics seeks to lock in future value with anti-cancer therapeutic patents	15/08/23
Roquefort files patent application for mRNA and RNA therapies	14/08/23
Roquefort Therapeutics Files International Patent for Anti-cancer Therapeutics	14/08/23
Roquefort Therapeutics plc Announces the Successful Filing of the International Phase PCT Patent for Its Proprietary Anti-Cancer mRNA and RNA Oligonucleotide Therapeutics	14/08/23
Roquefort Therapeutics making headway with siRNA	09/08/23
Roquefort announces new sirNA sequences and patent filing	07/08/23
Roquefort Therapeutics Completes Development of Four Novel Small Interfering RNA Sequences; Shares Up 5%	07/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Roquefort Therapeutics plc

Azioni

ROQ

GB00BMDQ2T15

Altre lingue

Filtri